Healthcare & Pharmaceuticals

Roche launches COVID-19 variant test to help monitor mutations

1 minute read

A logo of Swiss pharmaceutical company Roche is pictured in front of the company's building in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer

ZURICH, March 16 (Reuters) - Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus mutations, the Swiss pharmaceuticals group said on Tuesday. The test runs on widely used high-throughput systems and is for research purposes only.

"Periodic assessments against emerging variants have shown that Roche’s current diagnostic tests for detecting active SARS-CoV-2 infections remain accurate and effective," it said.

Register now for FREE unlimited access to
Reporting by Michael Shields Editing by Riham Alkousaa

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters